A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
About
Syantra is a precision biotechnology company focused on revolutionizing cancer detection and treatment. Their proprietary Onco-ID™ platform utilizes a blood-based liquid biopsy to detect early signs of cancer by analyzing shifts in the body's immune system and physiological responses, rather than directly looking for cancer cells. This approach aims to enable earlier diagnosis and more effective interventions.
Tags
Total Employees
14
Current headcount
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Syantra do?
Syantra is a precision biotechnology company focused on revolutionizing cancer detection and treatment. Their proprietary Onco-ID™ platform utilizes a blood-based liquid biopsy to detect early signs of cancer by analyzing shifts in the body's immune system and physiological responses, rather than directly looking for cancer cells. This approach aims to enable earlier diagnosis and more effective interventions.
How much funding has Syantra raised?
Syantra has raised a total of $11M in funding. The most recent round on record is Series A-1.
Where is Syantra headquartered?
Syantra is headquartered in Calgary, Canada.
When was Syantra founded?
Syantra was founded in 2016.
What industry does Syantra operate in?
Syantra operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.
How many employees does Syantra have?
Syantra has approximately 14 people on record.